MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Altered nucleus accumbens functional connectivity precedes apathy in Parkinson’s disease

    L. Morris, S. Harrison, T. Melzer, J. Dalrymple-Alford, T. Anderson, M. Macaskill, C. Le Heron (Christchurch, New Zealand)

    Objective: To investigate whether changes in connectivity between neural regions that are associated with goal-directed behaviour predict future development of apathy in people with Parkinson’s…
  • 2023 International Congress

    Differences in brain activity and oscillatory responses in resting and re-emergent tremor in Parkinson’s disease

    H. Ding, B. Nasseroleslami, J. Volkmann, G. Deuschl, S. Groppa, M. Muthuraman (Würzburg, Germany)

    Objective: To examine the differences in brain activity between resting and re-emergent tremor in PD, as well as to investigate the relationship between neuronal oscillatory…
  • 2023 International Congress

    Towards smart glasses for improved care of individuals with Parkinson’s disease

    I. Kiprijanovska, F. Panchevski, S. Stankoski, M. Gjoreski, J. Archer, J. Broulidakis, I. Mavridou, B. Hayes, T. Guerreiro, C. Nduka, H. Gjoreski (Brighton, United Kingdom)

    Objective: To evaluate the applicability of sensor-enabled smart glasses for remote tracking of symptoms related to Parkinson’s disease Background: Diagnosis and monitoring of PD by…
  • 2023 International Congress

    Empowerment of People with Parkinson`s disease: development, testing and evaluation of a cross-sectoral, intervention-based self-management program

    T. Thomsen, S. Skovbølling, M. Møller, V. Grønlund, M. Brønden, B. Biering-Sørensen (Glostrup, Denmark)

    Objective: The overall purpose of this study is to develop, test and evaluate the results of a self-management program targeted PwP with the aim of…
  • 2023 International Congress

    Glucocerebrosidase (GCase) activator, Ambroxol, reduces alpha-synuclein serine-129 phosphorylation and oligomers in mutant LRRK2 R1441G mouse brains

    Z. Choi, E. Chang, H. Liu, S. Zhang, Y. Ruan, K. Leung, S. Pang, M. Kung, D. Ramsden, S. Ho, P. Ho (Hong Kong, Hong Kong)

    Objective: To explore whether inducing brain GCase activity by Ambroxol™ (ABX; a brain-penetrant GCase activator) can reduce a-synuclein (αSyn) serine-129 phosphorylation and oligomer accumulation in…
  • 2023 International Congress

    Intrarater and interrater reliability of the 3 meter backward walk test in individuals with Parkinson disease.

    A. Boddy, K. Barta, L. Perry, M. Flores, K. Sawyer, A. Campbell (St Augustine, USA)

    Objective: Determine the intrarater and interrater reliability of the three meter backward walk (3 MBW) test for individuals diagnosed with Parkinson Disease. Background: Background- Parkinson…
  • 2023 International Congress

    The role of depression in the development of Impulse Control Disorders in Parkinson´s Disease.

    M. Vales Montero, F. Ferre Navarrete, J. Conejo Galindo, P. Melgarejo Otálora, P. Andrés Camarón, J. Suárez Campayo, R. Reyes Marrero, JR. López-Trabada Gómez, MB. Díaz Rodríguez, F. Grandas (Madrid, Spain)

    Objective: We aimed to investigate whether depression is associated with a higher risk of developing impulse control disorders (ICD) in Parkinson´s disease (PD) patients and…
  • 2023 International Congress

    Chromosomal Microarray Analysis for genetic evaluation of dystonia

    A. Saini, R. Rajan, R. Mewara, B. Verma, N. Gupta, D. Radhakrishnan, E. A, A. Gupta, V. Vy, M. Singh, R. Bhatia, A. Srivastava, M. Srivastava (New Delhi, India)

    Objective: To identify copy number variants (CNVs) associated with isolated or combined dystonia in Indian patients using chromosomal microarray analysis (CMA). Background: Chromosomal aberrations, especially…
  • 2023 International Congress

    Characteristics of Pain in Parkinson’s Disease with Arabic translation and validation of King’s Parkinson’s Disease Pain Scale

    T. Roushdy, E. Hamid, H. Salem, S. Reda, A. Shalash (cairo, Egypt)

    Objective: To translate and validate the King’s Parkinson’s Disease Pain Scale (KPPS) into Arabic and to correlate pain among PD patients with motor and non-motor…
  • 2023 International Congress

    Diffusion Tensor Imaging in GBA-related Parkinson’s disease

    R. Dayan, A. Bick, C. Muller, N. Levin, D. Arkadir (Jerusalem, Israel)

    Objective: To study the white matter involvement in Parkinson's patients with Glucocerebrosidase mutations (GBA-related PD). Background: While Parkinson's disease (PD) is a neurodegenerative disease with…
  • « Previous Page
  • 1
  • …
  • 218
  • 219
  • 220
  • 221
  • 222
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25179 (not found)
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • DaTscan in clinical evaluation of Multiple System Atrophy
  • Decision-making process for opicapone’s bedtime regimen
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley